Has Toya Gordon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $676 in general payments to Toya Gordon, MD across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Toya Gordon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Toya Gordon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Toya Gordon, MD

Gynecology · West Reading, PANPI 1538401260

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 34.3% of the total. Reporting peaked in 2024 at $296 and has fallen 66.3% since, to $100 in 2025. That places this record below the midpoint for gynecology clinicians in PA, where the typical reported total is $657.

$676in general payments, 2019–2025

Across 25 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$232
Boston Scientific$123
Medtronic$95
Astellas Pharma US Inc$54
Caldera Medical, Inc$53
Coloplast$48
plus $70 from 3 others

What the payments were for

Food & beverage$62292%
Gifts$538%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	11	$232
Boston Scientific	1	$123
Medtronic	4	$95
Astellas Pharma US Inc	2	$54
Caldera Medical, Inc	2	$53
Coloplast	2	$48
Bluewind Medical	1	$33
Teleflex LLC	1	$20
Integra Lifesciences Corporation	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ADVANTAGE FIT$123

How this compares

$676 in reported general payments places this provider in the 50th percentile of 98 gynecology providers in Pennsylvania.

See all gynecology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$82,044

Medicare patients

183

Services billed

4,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	67	$42,729
PremarinEstrogens, Conjugated	38	$16,177
MyrbetriqMirabegron	11	$11,736
Methenamine Hippurate	28	$1,090
Estradiol	15	$1,033
Clobetasol Propionate	30	$663
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	41	$656
Halobetasol Propionate	11	$335
Cephalexin	53	$302
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	21	$226
Imipramine Hcl	13	$115
Ciprofloxacin Hcl	15	$113
Oxycodone Hcl	27	$80
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet	11	$73
Ibuprofen	20	$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Astellas Pharma US IncMyrbetriq	$54	$11,73611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 98 gynecology providers in Pennsylvania.